Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6020657 | Journal of Neuroimmunology | 2013 | 8 Pages |
Abstract
In the present study, circulating proportions of CD8+ T (Tc) cell subsets, including IL-17 (Tc17) and IL-10 (Tc10) producing cells, were assessed in relapsing-remitting MS (RRMS) patients and a possible effect of beta interferon (IFN-β), glatiramer acetate (GA), and vitamin D (VitD) on these cell subsets was investigated. We show that both Tc17 and Tc10 cell fractions are elevated in the circulation of RRMS patients in remission compared to healthy subjects and that these Tc subsets remain unaffected by current immune modulating regimens.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
E. Peelen, M. Thewissen, S. Knippenberg, J. Smolders, A.-H. Muris, P. Menheere, J.W. Cohen Tervaert, R. Hupperts, J. Damoiseaux,